Skip to content
Menu

Avis Budget Group, Inc. CAR

Full chart Compare
Set alert

Price alert · CAR

All alert types
124.64 USD +1.78 (+1.45%)

Regular-session close

124.64 0.00 0.00%

After hours · Nov 17, 4:00 PM ET

123.11 Day range 126.87
85.96 52-week range 847.70
YTD
-2.87%
1 year
-3.72%

Discussion (99)

Mark CAR 7 months ago #72

$CAR $HIMS With short interest currently surging to over 40% of the float, HIMS is entering a massive squeeze window where reclaiming $24 tomorrow will likely force a wave of short-covering that accelerates momentum toward the $36 target by next week’s close. This setup is technically explosive given the thin liquidity and high cost-to-borrow, positioning the stock for a violent breakout as retail demand intersects with a structural supply crunch.

VICKY HANUKA CAR 3 years ago #74

$PTC Therapeutics(PTCT.US)$ ?????????????? Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.

sanjay CAR 5 years ago #78

Will close above 300. Shorts are scared now

Michelle Motta CAR 5 years ago #80

$CAR, omg just seeing this.. nice, but when are they going to make the playing field even?

Sign in to join the discussion